AzTrials
AzTrials

HypersalivationNCT04132765

Turkish Validation of The Drooling Impact Scale

An observational study of Hypersalivation and Cerebral Palsy, run by Marmara University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the reliability and construct validity of the Turkish version of the Drooling Impact Scale in children with cerebral palsy Read more about this study

Who is it for?
Ages 4 to 16 years
Conditions the study is for
Hypersalivation, Cerebral Palsy
What is being tested?
Drooling Impact Scale, Drooling Frequency and Severity Scale and The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD™)
Type of treatment
Pill or oral medicine
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Nov 2019to 30 Aug 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients with unilateral or bilateral, spastic, dyskinetic or mixed type cerebral palsy at between the ages of 4-16 and GMFCS level 3,4,5

Who may be able to join

  • Patients with unilateral or bilateral cerebral palsy at between the ages of 4-16
  • Spastic, dyskinetic or mixed type cerebral palsy
  • GMFCS level 3,4,5
  • Stable drooling within at least one month

Who cannot join

  • Active infection of salivary glands
  • Upper respiratory tract infection at the time of testing
  • History of anticholinergic drug intake in the past three weeks
  • Occurance of any above between test and re-test assessment that may interfere with the results

Trial locations and contacts

1 site in 1 country.

Evrim Karadag-Saygi, Prof contact

+902166570606162

evrimkaradag4@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Esra Giray

    Istanbul, 34899

    Esra Giray, 05558134394, girayesra@hotmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Reliability and Construct Validity of the Turkish Version of the Drooling Impact Scale Among Children With Cerebral Palsy

The aim of this study is to investigate the reliability and construct validity of the Turkish version of the Drooling Impact Scale in children with cerebral palsy

Read the detailed description

Drooling is common among several neurologic disorders such as cerebral palsy, Parkinson's disease, amyotrophic lateral sclerosis, which are the main diseases that physiatrist are one of the leading physicians involved in whose management 1. Drooling can be seen either as anterior drooling, unintentional leaving of saliva from mouth to outside of the body, or posterior drooling, invisible spill of saliva from mouth through pharyngeal isthmus and then to respiratory or digestive tract, inside the body 2. Anterior drooling causes psycho-social impairment, skin problems, infections, bad odor, dehydration, dentation problems and wet clothes and tools while posterior drooling may result in morbidity by posing a risk for aspiration pneumonia. Despite the frequency and significance of the condition, there is still a paucity of research and inadequate evidence about the various treatments and valid and reliable outcomes available. A major problem for research into interventions to reduce drooling is that there is no valid and reliable measurement tool of saliva control. There is no questionnaire in Turkish to evaluate the effects of drooling as well as drooling interventions.The aim of this study is to investigate the reliability and construct validity of the Turkish version of the Drooling Impact Scale in children with cerebral palsy.

Being tested
Drooling Impact Scale, Drooling Frequency and Severity Scale, The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD™), Drooling Quotient (DQ), Patient and caregiver visual analog scale (VAS) for drooling
Keywords
cerebral palsy, drooling impact scale, hypersalivation, validity
Medical subject headings
Sialorrhea, Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Drooling Impact ScaleOther

    A scale with 10 items which are scored with visual analog scale from1 to 10. Drooling impact increases with increased scores.

  • Drooling Frequency and Severity ScaleOther

    In this scale, parents or care givers were asked to rate the severity and frequency of drooling, classifying severity of drooling using a 5-level domain ranging from 1 (dry) to 5 (profuse drooling). The frequency of drooling was classified using a 4-level domain ranging from 1(no drooling) to 4 (constant drooling)

  • The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD™)Other

    A quality of life scale that measure caregivers' perspectives on the health status, comfort, well being, and ease of caregiving of children with severe developmental disabilities. CPCHILD consists of 36 items distributed over six sections representing the following domains: (1) Personal Care (eight items); (2) Positioning, Transfer, and Mobility (eight items); (3) Communication and Social Interaction (seven items); (4) Comfort, Emotions, and Behaviour (nine items); (5) Health (three items); and (6) Overall Quality Of Life (one item). For the sections which involve the performance of skills, the degree of difficulty of accomplishing each task or activity was rated on a 7-point ordinal scale anchored by 0 ('No problem at all') to 6 ('Impossible').

  • Drooling Quotient (DQ)Other

    DQ is a semi-quantitative method that assesses the presence of newly formed saliva on the lips every 15 seconds with 40 observations in 10 minutes, expressed as a percentage based on the ratio between the number of observed drooling episodes and the total number of observations.

  • Patient and caregiver visual analog scale (VAS) for droolingOther

    Patients will be asked to score their children's drooling severity on a visual analog scale (0-100 mm, 0 none to 100 severe)

  • Functional Oral Intake Scale (FOIS)Other

    Functional Oral Intake Scale (FOIS) which is a 7-point ordinal scale document the functional level of oral intake of food and liquid.

  • number of bibs daily usedOther

    Parents will be asked their children's number of bibs daily used.

  • number of hospital admissions per year related to respiratory infectionsOther

    Parents will be asked their children's number of hospital admissions per year related to respiratory infections.

  • Gross Motor Function Classification System (GMFCS)Other

    The GMFCS describes self-initiated movement and use of assistive devices (walkers, crutches, canes, wheelchairs) for mobility during an individual's usual activity.

  • Manual Ability Classification System (MACS)Other

    The MACS is also a simple, five-point ordinal classification system and was designed for use in children ages 4-18 years. The MACS is a validated measure in cerebral palsy that can be used to classify a child's typical use of both hands and upper limbs.

  • Communication Function Classification System (CFCS)Other

    The CFCS is a simple, five-point ordinal classification system that assesses everyday communication (not optimal communication) of children with cerebral palsy.

  • Eating and Drinking Ability Classification System (EDACS)Other

    EDACS is a measure to assess eating and drinking ability for children with CP, ages 3 and older. This classification is a simple five-point ordinal system.

Study groups in NCT04132765
Study groupRoleWhat they receive
Patients with cerebral palsyPatients with cerebral palsy at between the ages of 4-16 years and at Gross Motor Function Classification Levels of 3,4,5
Receives: Other: Drooling Impact Scale; Other: Drooling Frequency and Severity Scale; Other: The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD™); Other: Drooling Quotient (DQ); Other: Patient and caregiver visual analog scale (VAS) for drooling; Other: Functional Oral Intake Scale (FOIS); Other: number of bibs daily used; Other: number of hospital admissions per year related to respiratory infections; Other: Gross Motor Function Classification System (GMFCS); Other: Manual Ability Classification System (MACS); Other: Communication Function Classification System (CFCS); Other: Eating and Drinking Ability Classification System (EDACS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Drooling Impact Scale

    A scale with 10 items which are scored with visual analog scale from1 to 10. Drooling impact increases with increased scores.

    Measured: Day 0

  2. Drooling Impact Scale

    A scale with 10 items which are scored with visual analog scale from1 to 10. Drooling impact increases with increased scores.

    Measured: Day 3

Secondary outcomes (11)
  1. Drooling Frequency and Severity Scale

    n this scale, parents or care givers were asked to rate the severity and frequency of drooling, classifying severity of drooling using a 5-level domain ranging from 1 (dry) to 5 (profuse drooling). The frequency of drooling was classified using a 4-level domain ranging from 1(no drooling) to 4 (constant drooling)

    Measured: Day 0

  2. The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD™)

    A quality of life scale that measure caregivers' perspectives on the health status, comfort, well being, and ease of caregiving of children with severe developmental disabilities. CPCHILD consists of 36 items distributed over six sections representing the following domains: (1) Personal Care (eight items); (2) Positioning, Transfer, and Mobility (eight items); (3) Communication and Social Interaction (seven items); (4) Comfort, Emotions, and Behaviour (nine items); (5) Health (three items); and (6) Overall Quality Of Life (one item). For the sections which involve the performance of skills, the degree of difficulty of accomplishing each task or activity was rated on a 7-point ordinal scale anchored by 0 ('No problem at all') to 6 ('Impossible').

    Measured: Day 0

  3. Drooling Quotient (DQ)

    DQ is a semi-quantitative method that assesses the presence of newly formed saliva on the lips every 15 seconds with 40 observations in 10 minutes, expressed as a percentage based on the ratio between the number of observed drooling episodes and the total number of observations.

    Measured: Day 0

  4. Patient and caregiver visual analog scale (VAS) for drooling

    Patients will be asked to score their children's drooling severity on a visual analog scale.

    Measured: Day 0

  5. Functional Oral Intake Scale (FOIS)

    Functional Oral Intake Scale (FOIS) which is a 7-point ordinal scale document the functional level of oral intake of food and liquid.

    Measured: Day 0

  6. number of bibs daily used

    Parents will be asked their children's number of bibs daily used.

    Measured: Day 0

  7. number of hospital admissions per year related to respiratory infections

    Parents will be asked their children's number of hospital admissions per year related to respiratory infections.

    Measured: Day 0

  8. Gross Motor Function Classification System (GMFCS)

    The GMFCS describes self-initiated movement and use of assistive devices (walkers, crutches, canes, wheelchairs) for mobility during an individual's usual activity.

    Measured: Day 0

  9. Manual Ability Classification System (MACS)

    The MACS is also a simple, five-point ordinal classification system and was designed for use in children ages 4-18 years. The MACS is a validated measure in cerebral palsy that can be used to classify a child's typical use of both hands and upper limbs.

    Measured: Day 0

  10. Communication Function Classification System (CFCS)

    The CFCS is a simple, five-point ordinal classification system that assesses everyday communication (not optimal communication) of children with cerebral palsy.

    Measured: Day 0

  11. Eating and Drinking Ability Classification System (EDACS)

    EDACS is a measure to assess eating and drinking ability for children with CP, ages 3 and older. This classification is a simple five-point ordinal system.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2019
  2. Study start25 Nov 2019
  3. Primary completion30 Aug 2020 (estimated)
  4. Study completion30 Aug 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04132765
Sponsor's protocol ID
09.2019.963
Status last verified
Oct 2019
First submitted
17 Oct 2019
Last updated
27 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data that support the findings of this study will be available on request from the corresponding author (EG). The data will not be publicly available due to their containing information that could compromise the privacy of research participants.

Publications

  • Lakraj AA, Moghimi N, Jabbari B. Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel). 2013 May 21;5(5):1010-31. doi: 10.3390/toxins5051010.

    PubMed 23698357
  • Erasmus CE, van Hulst K, Rotteveel JJ, Willemsen MA, Jongerius PH. Clinical practice: swallowing problems in cerebral palsy. Eur J Pediatr. 2012 Mar;171(3):409-14. doi: 10.1007/s00431-011-1570-y. Epub 2011 Sep 20.

    PubMed 21932013
  • Pesheva P, Kuklinski S, Schmitz B, Probstmeier R. Galectin-3 promotes neural cell adhesion and neurite growth. J Neurosci Res. 1998 Dec 1;54(5):639-54. doi: 10.1002/(SICI)1097-4547(19981201)54:53.0.CO;2-2.

    PubMed 9843155

Questions about this trial

What is this clinical trial studying?

An observational study of Hypersalivation and Cerebral Palsy, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Esra Giray, MD (+905558134394, girayesra@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Drooling Impact Scale (time frame: Day 0). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04132765, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in